Poster
W
eD
. 7:30
am
—B
oston
C
onvention
& e
xhiBition
C
enter
,
e
xhiBit
h
alls
a-B
Presentation time: 12:30
pm
-2:30
pm
W11
1168.1 The development of antiseptic gel from
mangosteen shell extract.
A. Sangcakul and P. Ratananukul.
Fac. of Med., Ramathibodi Hosp., Mahidol Univ. and Fac. of
Sci., Srinakharinwirot Univ., Thailand.
W12
1168.2 Wound healing activity of (-)-borneol complexed
to chitosan bioactive film in rodents.
R.S.S. Barreto, D.S.
Prado, J.G. Galvão, J.K.M.C. Gonsalves, R.S. Nunes, R.L.C.
AlbuquerqueJúnior, R.C. Soares, W. de Lucca Júnior and L.
Quintans Júnior. Fed. Univ. of Sergipe and Tiradentes Univ.,
Brazil.
W13
1168.3 Lycopene inhibits cyclooxygenase-2 and
inflammatory mediator expression in microglia.
H-Y. Lin, H. Lin
and D-Y. Lu. Natl. Chung Hsing Univ. and China Med. Univ.
Grad. Inst. of Neural and Cognitive Sci., Taiwan.
W14
1168.4 Pro-resolving mediator production by
human phagocytes and their transcellular biosynthesis
with microparticles in inflammation-resolution.
J. Dalli, S.
Karamnov, M. Zhu, N. Petasis and C. Serhan. Brigham and
Women’s Hosp. and Harvard Med. Sch. and Univ. of Southern
California.
W15
1168.5 Plant-originated extract of Cucurbita maxim
sweet prevents foregut damage induced by entero-salivary
nitrites recirculation impair via suppression of inflammatory
mediators’ expression.
I. Pshyk-Titko, O. Zajachkivska and
A. Yaschenko. Lviv Med. Univ., Ukraine.
W16
1168.6 Gastroprotective effects of latex from
Himatanthus drasticus in models of acute gastric lesion.
R.S.P.
Pinheiro, L.M. Marques, L.B.N. Freitas, P. Bastos Luz, I.S.T.
Figueiredo, M. Matos, T. Souza, G. Rangel, M.V. Ramos and
N.M.N. Alencar. Fed. Univ. of Ceara, Brazil.
W17
1168.7 Antihyperalgesic effect of latex proteins from
Calotropis procera: involvement of inflammatory mediators.
P.
Bastos Luz, R.S.P. Pineiro, L.B.N. Freitas, F.S. Bitencourt,
K.S. Aragão, L.D. Carmo, T.S. Couto, M.V. Ramos and N.M.N.
Alencar. Fed. Univ. of Ceara, Brazil.
W18
1168.8 Aspirin influence on mice sex genders during
cutaneous wound healing.
J.S. Santos and A.M.A. Costa. Rio
de Janeiro State Univ.
W19
1168.9 Wound healing effect of TENS in rodents. A.S.
Barreto, R.S.S. Barreto, J.S.S. Quintans, I.O. Donato, R.S.D.
Cardoso, R.C. Soares, R.L.C. Albuquerque Júnior, W. de
Lucca Júnior, J.M. de Santana and L.J. Quintans Júnior.
Fed. Univ. of Sergipe and Tiradentes Univ., Brazil.
W20
1168.10 The inhibitory effects of Clitoria ternatea extract
on protein glycation, Amadori product and amyloid cross
b-structure formations. S. Yibchok-anun, P. Chayaratanasin
and S. Adisakwattana. Chulalongkorn Univ., Thailand.
W21
1168.11 Methanol extract of Ulmus pumila L. exerts
potent anti-inflammatory effects in murine macrophages and
mouse skin.
C. Ghosh, S.H. Yang and S.G. Hwang. Hankyong
Natl. Univ. and Natl. Inst. of Animal Sci., RDA, Suwon, South
Korea.
1167. NATURAL PRODUCTS I — SIGNALING
Poster
W
eD
. 7:30
am
—B
oston
C
onvention
& e
xhiBition
C
enter
,
e
xhiBit
h
alls
a-B
Presentation time: 12:30
pm
-2:30
pm
W1
1167.1 Antinociceptive effect of p-cymene in mice –
evidence of involvement of periaqueductal gray area.
J.S.S.
Quintans, M.F. de Santana, R.G. Brito, W. de Lucca Júnior
and L. Quintans Júnior. Fed. Univ. of Sergipe, Brazil.
W2
1167.2 R-Equol-induced nongenomic estrogenic
effects and interactions with estradiol signaling.
M.K. Saraf,
Y-J. Jeng and C.S. Watson. Univ. of Texas Med. Branch.
W3
1167.3 The effects of (-)-epigallocatechin-3-gallate and
phosphatidylinositol 3-kinase inhibition on Burkitt lymphoma
cells.
A.M. Domina and C-C. Van Doorn. Husson Univ. Sch. of
Pharm.. ME.
W4
1167.4 In vivo and in vitro citotoxic activity of
Hylocereus undatus fruit extract in cancer cells.
T. Uribe
Calvillo, A. Soriano, A. Michel Rosales, M. Jimenez Estrada,
E. Peña Beltrán and I. Delgado Enciso. Univ. of Colima,
Colima and Tecomán, Mexico and Natl. Autonomous Univ. of
Mexico, Mexico City.
W5
1167.5 Antibacterial activity of methanolic extracts
from Dunaliella salina and Chlorella vulgaris.
N.B. Medina-
Jaritz, L.F. Carmona-Ugalde, J.C. Lopez-Cedillo and S.L.
Ruiloba-De Leon F. Natl. Polytech Inst., Mexico City.
W6
1167.6 Effect of EGCG on the expression and activity
of P-glycoprotein in breast cancer cells.
A.I. Gonzaga Morales
, L. Rodriguez Fragoso and J. Reyes Esparza. Fac. of Pharm.
UAEM, Cuernavaca.
W7
1167.7 Marine pharmacology and the marine
pharmaceuticals pipeline.
A.M.S. Mayer and K.B. Glaser.
Midwestern Univ., IL and Abbott Labs.
W8
1167.8 Cordyceps sinensis Cs-5 enhances sexual
functions in normal and impotent models.
J-Y. Yang, Y. Zhang,
Y-Z. Dong, N-Z. Tan, J-H. Lu and J-S. Zhu. Pharmanex Beijing
Pharmacol. Ctr., NS Ctr. for Anti-Aging Res., Provo, UT and
Hong Kong Polytech Univ.
W9
1167.9 The antidiabetic activities of the aqueous leaf
extract of Phyllanthus amarus in some laboratory animals.
A.A.
Adedapo and S.O. Ofuegbe. Univ. of Ibadan, Nigeria.
W10
1167.10 Acute toxicity evaluation of Genipa americana
L. (Rubiaceae).
K.P. Cavalcanti, G.C. Jimenez, E.C.B. Silva,
F.B.R. Anjos, I.A. Souza and A.S. Cabrita. Fed. Univ. of
Pernambuco, and Fed. Rural Univ. of Pernambuco, Brazil and
Univ. of Coimbra, Portugal.
PHARMACOLOGY WEDNESDAY
413
W
E
D
1169. DIABETES, GLYCEMIA AND METABOLISM
Poster
W
eD
. 7:30
am
—B
oston
C
onvention
& e
xhiBition
C
enter
,
e
xhiBit
h
alls
a-B
Presentation time: 12:30
pm
-2:30
pm
W22
1169.1 Increased inducibility of ventricular tachycardia
in the type I diabetic Akita mouse is associated with
abnormalities of Ca
2+
homeostasis and reversed by pravastatin.
H. Jin, M. Rajab, M. Aronovitz, B. Wang, H-J. Park, M. Link
and J. Galper. Tufts Med. Ctr.
W23
1169.2 Effect of L-tryptophan on cytoprotection against
long-term postprandial hyperglycemia-induced esophageal
damage in rats.
N.R. Hrytsevych, O. Zayachkivska and A.
Yaschenko. Lviv Natl. Med. Univ., Ukraine.
W24
1169.3 A novel AMPK activator, PT-1, increases
gamma1 AMPK-associated activity, but not gamma3 AMPK-
associated activity or glucose transport.
T.E. Jensen, J.B. Birk
and E.A. Richter. Univ. of Copenhagen.
W25
1169.4 Evaluation of hypoglycemic and anti-diabetic
activity of polyherbal formulation in normal and streptozotocin-
induced diabetic rats.
V. Sabbani, R. Alluri and S. Satla. Sitha
Inst. of Pharmaceut. Sci. , Vishnu Inst. of Pharmaceut. Educ.
and Res. and Jawaharlal Nehru Technol. Univ., Hyderabad ,
India.
W26
1169.5 Opioid-mediated sustained ligand-activated
preconditioning induces cardiac protection in type II diabetes
mellitus.
L.E. See Hoe, A. Zemljic-Harpf, J. Schilling,
C. Finley, S. Kellerhals, D. Roth, J. Peart, H. Patel and J.
Headrick. Griffith Univ., Australia, UCSD and VA San Diego
Healthcare Syst.
W27
1169.6 Stromelysin-1(MMP3) worsens the
neurovascular injury in hyperglycemic stroke.
S. Hafez, M.
Abdelsaid, M. Coucha and A. Ergul. Univ. of Georgia and
Georgia Hlth. Sci. Univ.
W28
1169.7 Angiotensin AT2R activation prevents adiposity
under high-fat diet condition in ovariectomized mice.
S. Nag
and T. Hussain. Univ. of Houston.
W29
1169.8 The neuroprotective effect of cerebrolysin
against type 1 diabetes-induced dementia in rats.
N.N. Nassar,
G.S. Georgy, H.A. Mansour and D.M. Abdallah. Fac. of
Pharm., Cairo Univ. and Natl. Org. of Drug Control and Res.,
Giza, Egypt.
W30
1169.9 JNK1 phosphorylation of HNF4
a represses
miR-122, which causes PTP1B induction.
Y.M. Yang, S.Y. Seo,
T.H. Kim and S.G. Kim. Col. of Pharm., Seoul Natl. Univ.
W31
1169.10 Adiponectin restores diabetic heart sensitivity
to ischemic posctconditioning: role of STAT3 activation.
H. Li,
T. Wang, S. Lei, K-f. Ng, M. Irwin, A. Xu and Z. Xia. The Univ.
of Hong Kong and Affiliated Hosp. of Guangdong Med. Col.,
China.
W32
1169.11 Moxonidine as an insulin sensitizing agent. L.P.
Edwards, M. Cheema and C. Nunemaker. Loma Linda Univ.
and Univ. of Virginia Hlth. Syst.
W33
1169.12 The prostaglandin F2alpha/calcineurin-
signaling pathway inhibits adipogenesis via the autocrine
actions of an IL-11/gp130/STAT1-dependent signaling cascade.
D. Annamalai and N.A. Clipstone. Loyola Univ. Chicago,
Maywood.
W34
1169.13 Cerebro-vasculoprotective effects of azilsartan
medoxomil in diabetes.
M.A. Abdelsaid, M.M. Coucha and A.
Ergul. Georgia Hlth. Sci. Univ.
W35
1169.14 The influence of ethanol on the hyperglycemia
and renal activities of glycolytic and gluconeogenic enzymes of
diabetic rats.
S.N. Patel, M.C. Parikh, C.R. Ashby, Jr. and C.A.
Lau-Cam. Col. of Pharm. and Hlth. Sci., St. John’s Univ., NY.
W36
1169.15 AMP-activated protein kinase as regulator of
P2Y6 receptor-induced insulin secretion in mouse pancreatic
beta cells.
R. Balasubramanian, H. Maruoka, S.M.P.
Jayasekara, Z. Gao and K.A. Jacobson. NIDDK, NIH.
W37
1169.16 Imidacloprid induces insulin resistance by
protein kinase B mediated mechanism.
J. Kim, Y. Park, K.S.
Yoon, J.M. Clark and Y. Park. Univ. of Massachusetts Amherst
and Korea Univ.
W38
1169.17 The effect of a DPP4 inhibitor on morphometry
of pancreatic beta cells after lactation on female Wistar rats.
V. Suen, D. Ribas-Filho, E. Cersosimo, A. Martins, J.S.
Marchini and R. Azoubel. São Paulo Univ., Ribeirão Preto,
Brazilian Assn. of Nutrol. ABRAN, Sch. of Med. Padre Albino,
Brazil and Univ. of Texas at San Antonio.
W39
1169.18 Effect of ER stress in collagen 6A3 and aTF3
expression in adipocytes.
M.K. Saraf, S. Choudhary, M.
Chandalia and N. Abate. Univ. of Texas Med. Branch.
W40
1169.19 Prostaglandin E
2
EP3 receptor modulation of
insulin secretion in diabetes.
R.P. Ceddia, M. Gannon and
R.M. Breyer. Vanderbilt Univ.
W41
1169.20 Pregnane X receptor mediates dyslipidemia
induced by the HIV protease inhibitor amprenavir in mice.
R.N.
Helsley, Y. Sui, N. Ai, S-H. Park, W.J. Welsh and C. Zhou.
Univ. of Kentucky and UMDNJ, Piscataway.
1170. ENDOCRINE PHARMACOLOGY
Poster
W
eD
. 7:30
am
—B
oston
C
onvention
& e
xhiBition
C
enter
,
e
xhiBit
h
alls
a-B
Presentation time: 12:30
pm
-2:30
pm
W42
1170.1 Characterization of recombinant traceable
analogs of the parathyroid hormone.
F. Marceau, X. Charest-
Morin, M-T. Bawolak, R. Lodge, I. Allaeys, P.E. Poubelle and
J-P. Fortin. CHU de Québec Res Ctr. and Tufts Med. Ctr.
W43
1170.2 Characterization of MT1 melatonin receptor
expressing neurons in the medial habenula, habenula
commissure and periaqueductal grey of the C3H/HeN mouse
brain.
K.M. Evely, E.B. Adamah-Biassi, R.L. Hudson and
M.L. Dubocovich. Univ. at Buffalo Sch. of Med. and Biomed.
Sci.
W44
1170.3 Role of cytosolic glucocorticoid receptor
and annexin-A1 on neutrophil traffic from bone marrow into
blood: SDF-1alpha/CXCR-4/CXCR-2 axis.
S.H.P. Farsky, I.D.
Machado, J.R. Santin, V.P. Ferraz, C.D. Gil, S.M. Oliani and
M. Perretti. Univ. of São Paulo, Fed. Univ. of São Paulo, São
Paulo State Univ. and Barts and The London Sch. of Med. and
Dent.
W45
1170.4 Effect of enalapril and losartan on testosterone
induced benign prostatic hyperplasia in rats.
S.B. Patel, V.
Patel and H. Captan. Indukaka Ipcowala Col. of Pharm. and
A.R. Col. of Pharm., Anand, India.
WEDNESDAY PHARMACOLOGY
414
1171. GPCR: BIASED AGONIST SIGNALING
Poster
W
eD
. 7:30
am
—B
oston
C
onvention
& e
xhiBition
C
enter
,
e
xhiBit
h
alls
a-B
Presentation time: 12:30
pm
-2:30
pm
W46
1171.1 Functional selectivity of ligands at the dopamine
D2L dopamine receptor.
T. Brust and V. Watts. Purdue Univ.
W47
1171.2 Biased signaling by proteinase-activated
receptor 1 via activation with neutrophil and cockroach serine
proteinases: tracking of distinct receptor dynamics with dual
fluorochrome tagged receptors.
M.D. Hollenberg, D. Polley, R.
Ramachandran and K. Mihara. Univ. of Calgary Fac. of Med.,
Canada.
W48
1171.3 Development of biased agonists at the kappa
opioid receptor.
A. Phillips, L. Zhou, K. Lovell, K. Frankowski,
S. Slausen, T.E. Prisinzano, J. Aube and L.M. Bohn. The
Scripps Res. Inst., Jupiter, FL and Univ. of Kansas.
W49
1171.4 Novel positive allosteric modulators bias
acetylcholine signaling at human M
4
muscarinic receptors.
M.T. Klein, G. Digby, C. Niswender, C. Tarr, M. Poslusney, B.
Melancon, M. Wood, C. Lindsley and P.J. Conn. Vanderbilt
Univ. Med. Ctr.
W50
1171.5 KF83959 is a partial agonist, not a functionally
selective dopamine D
1
receptor ligand as commonly believed.
S-M. Lee, V. Murthy and R. Mailman. Penn State, Hershey.
W51
1171.6 Cockroach allergen proteinases regulate
proteinase-activated receptor-1signaling.
D. Polley, K. Mihara,
R. Ramachandran, H. Vliagoftis, S. Boitano, M.D. Hollenberg
and M. Daines. Univ. of Calgary, Canada, Univ. of Alberta and
Univ. of Arizona.
W52
1171.7 The atypical antipsychotic clozapine induces
5-HT2AR-mediated signaling and behavioral events in a
beta-arrestin2-independent but Akt-dependent manner.
C.L.
Schmid, J.M. Streicher and L.M. Bohn. The Scripps Res. Inst.
1172. GPCR KINASES AND
B-ARRESTINS
Poster
W
eD
. 7:30
am
—B
oston
C
onvention
& e
xhiBition
C
enter
,
e
xhiBit
h
alls
a-B
Presentation time: 12:30
pm
-2:30
pm
W53
1172.1 Mapping the binding of G protein–coupled
receptor kinases 4
g with Ga
s
.
J.H. Nguyen, A.E. Lacuran, P.
Oelschlaeger and B.T. Andresen. Western Univ. of Hlth. Sci.
and Univ. of Missouri-Columbia.
W54
1172.2 Insights into selectivity from rationally designed
inhibitors of G protein-coupled receptor kinase 2.
K. Homan, M.
Wilson, S. Larsen and J. Tesmer. Univ. of Michigan.
W55
1172.3 Desensitization of the P2Y
1
receptor in
platelets.
T. Blatt, W. Bergmeier and R. Nicholas. Univ. of
North Carolina at Chapel Hill.
W56
1172.4 G protein-coupled receptor kinase 2 is
localized to centrosomes and mediates epidermal growth
factor-promoted separation of duplicated centrosomes.
C. So,
A. Michal and J. Benovic. Thomas Jefferson Univ.
W57
1172.5 Differences in
b-arrestin dependent signaling
by PAR2 and NK1R are directed by their C terminal tails.
K. Pal
and K. Defea. Univ. of California , Riverside.
W58
1172.6
b-Arrestin dependent signaling of metabotropic
glutamate receptor 1.
H.A. Hathaway, S. Pshenichkin, J.O.
DiRaddo, T. Gelb, E. Grajkowska and J.T. Wroblewski.
Georgetown Univ.
W59
1172.7 Amino acids within intracellular loop 3 of the
D2 dopamine receptor are necessary for arrestin binding and
receptor internalization.
C.C. Clayton and K.A. Neve. Oregon
Hlth. & Sci. Univ. and Portland VA Med. Ctr.
W60
1172.8 Non-canonical signaling by GPCR-arrestin-
G
bg ternary complexes. V.L. Wehbi, T.N. Feinstein and J-P.
Vilardaga. Univ. of Pittsburgh Sch. of Med.
W61
1172.9 Differential
b-arrestin2 requirements of
constitutive and agonist-induced internalization of the CB1
cannabinoid receptor.
P. Gyombolai, E. Boros, L. Hunyady
and G. Turu. Semmelweis Univ., Hungary.
W62
1172.10 Proteomic assessment of the binding
partners of GRK4
g: an approach to understand the molecular
mechanisms of GRK4
g action. J.H. Nguyen, J. Liu, C.W.
Adams and B.T. Andresen. Western Univ. of Hlth. Sci., Keck
Grad. Inst., Claremont, CA and Univ. of Missouri-Columbia.
W63
1172.11 The role of kinase and RGS activity of GRKs in
regulating the dopaminergic signaling in hemiparkinsonian rats.
M.R. Ahmed, V.V. Gurevich and E.V. Gurevich. Vanderbilt
Univ. Med. Ctr.
1173. GPCR TRAFFICKING AND DESENSITIZATION
Poster
W
eD
. 7:30
am
—B
oston
C
onvention
& e
xhiBition
C
enter
,
e
xhiBit
h
alls
a-B
Presentation time: 12:30
pm
-2:30
pm
W64
1173.1 Rab26 mediates the Golgi-to-cell surface
transport of
a2-adrenergic receptors. C. Li, Y. Fan, T-H. Lan, N.
Lambert and G. Wu. Georgia Hlth. Sci. Univ.
W65
1173.2 A single Lys residue on the first intracellular
loop modulates the endoplasmic reticulum export and cell-
surface expression of
a2A-adrenergic receptor. Y. Fan, C. Li
and G. Wu. Georgia Hlth. Sci. Univ.
W66
1173.3 Sphingosine-1 phosphate receptor-1
desensitization mediated by isoforms of protein kinase C:
receptor phosphorylation.
M.A. Morquecho-León, S. Bazúa-
Valenti, M.T. Romero-Ávila and J.A. García-Sáinz. UNAM,
Mexico City.
W67
1173.4 Serine 363 is required for NOPR desensitization,
internalization, and arrestin signaling.
N. Zhang, W. Planer,
E.R. Siuda, H-C. Zhao, L. Stickler, S.D. Chang, M.A. Baird,
Dostları ilə paylaş: |